Skip to content

Valgus bracing.

The effectiveness of two different valgus braces in the treatment of varus medial compartment osteoarthritis of the knee: A randomized clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26399
Enrollment
80
Registered
2010-07-13
Start date
2010-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Valgus bracing, unicompartmental osteoarhritis, varus knee, RCT

Interventions

Trial arm 1: 3 months prescription of the Bledsoe Thruster Brace. Trial arm 2: 3 months prescription of the SofTec OA Brace.

Sponsors

Maatschap orthopaedie ziekenhuis Rijnstate
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with medial knee osteoarthritis (confirmed on x-ray (AP and lateral) using the Kellgren classification); 2. Medial knee pain; 3. Varus leg alignment (confirmed on X-ray); 4. Age between 18-70.

Exclusion criteria

Exclusion criteria: 1. Insufficient command of the Dutch language; 2. The inability to apply brace because of physical or cognitive limitations; 3. Symptomatic back/hip/ankle/foot pathology (which makes improvement of pain, function, quality of life and satisfaction, by wearing a brace, impossible); 4. Other than osteoarthritis causing knee pain (like arthritis); 5. Pre-existing skin problems.

Design outcomes

Primary

MeasureTime frame
Difference in the VAS pain score at 3 months between the Bledsoe Thruster group and the SofTec OA Brace group.

Secondary

MeasureTime frame
1. Visual Analogue Scale for pain and satisfacion (VAS-pain, VAS-satisfaction); 2. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC); 3. The SF-12 and the 6-Minutes Walking. Test at baseline, 2 weeks and 3 months. Radiographs of varus leg alignment at baseline without brace and at 3 months with brace. Patients need to keep a diary once a week during the 3 months of participation. In this diary they record mean daily analgesics use, complications and compliance.

Contacts

Public ContactS. Grinsven, van

Wagnerlaan 55

SvanGrinsven@Alysis.nl+31 (0)88 0056366

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)